Tension grips Chikkamagaluru ahead of Datta Jayanti

New Delhi, Mar 26: While the humans are on lockdown and spending time with their families, animals are free and without any fear roaming around on the otherwise busy roads. From Malabar civets to large Indian bisons, animals are enjoying this time.

Indian Forest Officer Susanta Nanda recently shared a video with the caption, "Indian bison( the gaur) goes for a street walk. The largest extant Bovine, is native to South and Southeast Asia. It can be very aggressive. Rare to see in markets."

The 8-second video shows the large animal freely walking in the market area of Chikmagalur district, Karnataka, while the few onlookers on the road get aside and watch the Bison with utmost amazement.

The videos of animals having a gala time on the roads have become common. After the video was posted online, it became a hit. The clip garnered over 3.1k views and over 100 retweets.

Twitter is amazed at the video. Have a look at the comments.

One user wrote, "Oh! We should vacate this place for them. Guess humans have stayed for too long."

Another Twitter user wrote, "That’s one thing people would follow social distancing with!"

Bengaluru, Jul 12: KCTET 2020: Attention candidates, the Karnataka Deputy Chief Minister has confirmed the exam dates for Karnataka Common Entrance Test, KCET 2020.

As per information, KCET 2020 will be held between July 30 and July 31.

Karnataka Common Entrance Test or KCET is an examination which is held for admission to BTech courses in the state’s institutes.

The Higher Education Minister C N Ashwathnarayan, took to twitter to confirm the KCET dates. The Minister tweeted:

“The K-CET 2020 examinations will be held on the decided dates of July 30 & July 31. All the best to all the students!”

Details regarding KCET exam centers, time, and schedule will be mentioned in the admit card. Candidates can download their admit card fro the official website of KEA i.e. cetonline.karnataka.gov.in.

KCET 2020 was earlier scheduled to be held from April 22 to April 24, 2020, however, due to the ongoing coronavirus outbreak, KEA postponed KCET 2020 exams.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.